Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis

Azziz, 1989, Adenomyosis: current perspectives, Obstet Gynecol Clin North Am, 16, 221, 10.1016/S0889-8545(21)00148-0

Fong, 1999, Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system, Contraception, 60, 173, 10.1016/S0010-7824(99)00075-X

Bragheto, 2007, Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging, Contraception, 76, 195, 10.1016/j.contraception.2007.05.091

Arnold, 1995, The nonsurgical diagnosis of adenomyosis, Obstet Gynecol, 86, 461, 10.1016/0029-7844(95)00193-U

Dueholm, 2007, Transvaginal ultrasound or MRI for diagnosis of adenomyosis, Curr Opin Obstet Gynecol, 19, 505, 10.1097/GCO.0b013e3282f1bf00

Benagiano, 2009, Adenomyosis: new knowledge is generating new treatment strategies, Womens Health, 5, 297

Wood, 1998, Surgical and medical treatment of adenomyosis, Hum Reprod Update, 4, 323, 10.1093/humupd/4.4.323

Phillips, 1995, Endomyometrial resection of menopausal women with annoying uterine bleeding on estrogen replacement therapy, J Am Assoc Gynecol Laparosc, 2, 19

Englander, 2008, Uterine artery embolization for the treatment of adenomyosis, Semin Intervent Radiol, 25, 387, 10.1055/s-0028-1102994

Yoon, 2008, Successful use of magnetic resonance-guided focused ultrasound surgery to relieve symptoms in a patient with symptomatic focal adenomyosis, Fertil Steril, 90, 2018.e13, 10.1016/j.fertnstert.2008.05.028

Fedele, 1997, Treatment of adenomyosis-associated HMB with a levonorgestrel-releasing intrauterine device, Fertil Steril, 68, 426, 10.1016/S0015-0282(97)00245-8

Cho, 2008, Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis, Am J Obstet Gynecol, 198, 373, 10.1016/j.ajog.2007.10.798

Sheng, 2009, The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis, Contraception, 79, 189, 10.1016/j.contraception.2008.11.004

Ozdegirmenci, 2011, Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis, Fertil Steril, 95, 497, 10.1016/j.fertnstert.2010.10.009

Dueholm, 2001, Magnetic resonance imaging and transvaginal ultrasonography for diagnosis of adenomyosis, Fertil Steril, 76, 588, 10.1016/S0015-0282(01)01962-8

Reinhold, 1995, Diffuse uterine adenomyosis: morphologic criteria and diagnostic accuracy of endovaginal sonography, Radiology, 197, 609, 10.1148/radiology.197.3.7480727

Nelson, 2007, Contraindications to IUD and IUS use, Contraception, 75, S76, 10.1016/j.contraception.2007.01.004

Silverberg, 1986, Endometrial morphology during long-term use of levonorgestrel releasing intrauterine device, Int J Gynecol Pathol, 5, 235, 10.1097/00004347-198609000-00005

Luukkainen, 1990, Levonorgestrel-releasing intrauterine device, Ann Med, 22, 85, 10.3109/07853899009147248

Rogers, 1993, Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel, Hum Reprod, 8, 1396, 10.1093/oxfordjournals.humrep.a138268

Hickey, 1999, Changes in vascular basement membrane in the endometrium of Norplant users, Hum Reprod, 14, 716, 10.1093/humrep/14.3.716

Jondet, 2005, Endometrial vascularization in levonorgestrel intrauterine device users; computerized microvessel measurement study, Contraception, 71, 60, 10.1016/j.contraception.2004.07.002

Stephanie, 2007, Endometrial vessel maturation in women exposed to levonorgestrel releasing intrauterine system for a short or prolonged period of time, Hum Reprod, 22, 3084, 10.1093/humrep/dem238

Petta, 1996, The use of vaginal ultrasound to identify copper T IUDs at high risk of expulsion, Contraception, 54, 287, 10.1016/S0010-7824(96)00181-3

Rivera, 1999, Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD, Contraception, 60, 155, 10.1016/S0010-7824(99)00077-3

Bahamondes, 1995, Performance of copper intrauterine devices when inserted after an expulsion, Hum Reprod, 10, 2917, 10.1093/oxfordjournals.humrep.a135819

Thonneau, 2001, Risk factors for intrauterine device failure: a review, Contraception, 64, 33, 10.1016/S0010-7824(01)00215-3

Castro, 1993, The clinical performance of the Multiload IUD: I. The influence of the endometrial cavity length, Adv Contracept, 9, 285, 10.1007/BF01983205

Zhang, 1993, Factors associated with copper T IUD removal for bleeding/pain: a multivariate analysis, Contraception, 48, 13, 10.1016/0010-7824(93)90061-B

Merki-Feld, 2008, Partial and complete expulsion of the Multiload 375 IUD and the levonorgestrel-releasing IUD after correct insertion, Eur J Obstet Gynecol Reprod Biol, 137, 92, 10.1016/j.ejogrb.2007.02.003

Sivin, 1991, Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDs, Contraception, 44, 473, 10.1016/0010-7824(91)90149-A

UNDP/UNFPA/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction: IUD Research Group, 1994, A randomized multicentre trial of the Multiload 375 and TCu380A IUDs in parous women: three-year results, Contraception, 49, 543, 10.1016/0010-7824(94)90094-9

Fedele, 1992, Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis, Fertil Steril, 58, 94, 10.1016/S0015-0282(16)55142-5

Bazot, 2001, Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology, Hum Reprod, 16, 2427, 10.1093/humrep/16.11.2427